WEISZ, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 7889
EU - Europa 2477
AS - Asia 920
Continente sconosciuto - Info sul continente non disponibili 12
AF - Africa 4
SA - Sud America 3
Totale 11305
Nazione #
US - Stati Uniti d'America 7880
IT - Italia 890
UA - Ucraina 671
CN - Cina 607
IE - Irlanda 307
DE - Germania 239
VN - Vietnam 177
SE - Svezia 136
FI - Finlandia 134
TR - Turchia 101
NL - Olanda 20
FR - Francia 15
RU - Federazione Russa 15
EU - Europa 12
IN - India 12
GB - Regno Unito 11
CH - Svizzera 10
CA - Canada 8
AT - Austria 5
BE - Belgio 5
RO - Romania 5
DK - Danimarca 3
HK - Hong Kong 3
JP - Giappone 3
TW - Taiwan 3
BD - Bangladesh 2
BR - Brasile 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HR - Croazia 2
IL - Israele 2
KR - Corea 2
PH - Filippine 2
PL - Polonia 2
PT - Portogallo 2
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
ES - Italia 1
MN - Mongolia 1
MY - Malesia 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 11305
Città #
Ann Arbor 2199
Chandler 1044
Wilmington 848
Jacksonville 847
Princeton 693
Woodbridge 627
Houston 393
Dublin 291
Salerno 193
Dong Ket 174
Andover 162
Nanjing 158
Boardman 112
Izmir 101
Pellezzano 101
Beijing 88
Mestre 80
Fairfield 67
Naples 62
Dearborn 60
Shenyang 60
Hebei 57
Düsseldorf 51
Ashburn 47
Nanchang 45
Changsha 43
Jiaxing 36
Norwalk 31
Tianjin 27
Jinan 22
Falls Church 20
Redwood City 20
Cambridge 18
Matera 17
Nürnberg 16
Guangzhou 14
Zhengzhou 13
San Diego 11
Venezia 10
Renton 7
Pisa 6
Potenza 6
Seattle 6
Hangzhou 5
Indiana 5
Napoli 5
San Giorgio A Cremano 5
Taizhou 5
Vienna 5
Yellow Springs 5
Arzano 4
Avigliano 4
Eboli 4
Florence 4
Lanzhou 4
Pavia 4
Redmond 4
San Mango 4
South El Monte 4
Taglio Di Po 4
Atlanta 3
Fisciano 3
Fremont 3
Hanoi 3
Hefei 3
Helsinki 3
Milan 3
Ottawa 3
Rome 3
Taipei 3
Tokyo 3
Xian 3
Zurich 3
Ahmedabad 2
Amsterdam 2
Aveiro 2
Avellino 2
Benevento 2
Bergamo 2
Brescia 2
Cagliari 2
Caserta 2
Catanzaro 2
Chicago 2
Cicciano 2
Copenhagen 2
Costa Mesa 2
Groningen 2
Haikou 2
Iwiczna 2
Kishorganj 2
Latina 2
Lecce 2
London 2
Marigliano 2
Messina 2
Montréal 2
New Delhi 2
Philadelphia 2
Sabaudia 2
Totale 9051
Nome #
Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells 333
iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data 127
Identification of Genes Selectively Regulated in Human Hepatoma Cells by Treatment With Dyslipidemic Sera and PUFAs 122
Infantile spasms in early-onset Niemann-Pick disease with a novel compound heterozygous mutations in SMPD1 gene. 116
Expression of c-jun acts is not mandatory for mouse hepatocyte proliferation induced by two ligands of nuclear receptors: TCPOBOP and T3. 114
Analysis of gene expression modulation by exposure to low frequency (LF) electric fields 114
Small non-coding RNA deregulation in endometrial carcinogenesis 114
Single-cell states in the estrogen response of breast cancer cell lines. 112
Small RNA profiling reveals deregulated PTEN/PI3K/Akt pathway in asthmatic bronchial smooth muscle cells. 111
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 110
Relationship between mutations in DNA sequences loci coding pre-miRNAs and genes related to biogenesis of sncRNAs with miRNA expression in endometrial carcinoma tissues. 108
The AKT/IL-6/STAT3 pathway regulates growth of lung tumor initiating cells. 100
DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells 100
LF electric fields exposure of bone cultured cells. Effects on gene expression 98
Effect of LF Electric Fields on Gene Expression of Bone Cultured Cells 98
Global Analysis of Estrogen Receptor Beta Binding to Breast Cancer Cell Genome Reveals Extensive Interplay with Estrogen Receptor Alpha for Target Gene Regulation. 96
Post-transcriptional regulation of human breast cancer cell proteome by unliganded Estrogen Receptor beta via microRNAs. 96
Design and expression of peptides with antimicrobial activity against Salmonella typhimurium 95
Effect of low frequency (LF) electric fields on gene expression of a bone human cell line. 94
Leptin as a Mediator of Tumor-Stromal Interactions Promotes Breast Cancer Stem Cell Activity. 94
New Insights on Estrogen Receptor Actions in Hormone-responsive Breast Cancer Cells by Interaction Proteomics 93
Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma 93
Estradiol and progesterone receptors in malignant gastrointestinal tumors. 91
Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells 91
Genome-wide analysis of unliganded estrogen receptor binding sites in breast cancer cells. 91
Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations. 91
Malignant mammary cells acquire independence from extracellular context for regulation of estrogen receptor alpha. 90
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 89
Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells 89
MicroRNA (miRNA) and piwi-interacting RNA (piRNA) signature of human primary bronchial epithelial cells (PBEC) after exposure to mainstream cigarette smoke (MCS) 89
Estrogen Actions in Hormone-responsive Cancer Cells 88
Molecular bases of copper and iron deficiency-associated dyslipidemia: a microarray analysis of the rat intestinal transcriptome. 87
Estrogen Receptor α Controls a Gene Network in Luminal-like Breast Cancer Cells Comprising Multiple Transcription Factors and microRNAs. 86
Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional de-repression via c-Jun/c-Fos/Estrogen Receptor (Progesterone Receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. 86
Identification of H ferritin-dependent and independent genes in K562 differentiating cells by targeted gene silencing and expression profiling. 86
Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells 86
Specific inhibition of NF-Y subunits triggers different cell proliferation defects. 85
Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells 85
Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. 84
A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. 83
Steroid derivatives for electrophilic affinity labelling of glucocorticoid binding sites: interaction with the glucocorticoid receptor and biological activity. 83
Review of: The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements 83
iMir: an integrated pipeline for high-throughput analysis of small non-coding RNA data obtained by smallRNA-Seq. 83
Global transcriptome profiles of Italian Mediterranean buffalo embryos with normal and retarded growth. 81
C/EBPδ gene targets in human keratinocytes. 80
The reverse transcription inhibitor Abacavir shows anticancer activity in PC3 prostate cancer cell line. 80
Interaction of sodium molybdate with highly purified glucocorticoid receptor. 80
Constitutive overexpression of cyclin D1 does not prevent inhibition of hormone-responsive human breast cancer cell growth by antiestrogens. 80
Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells. 79
IBTK differently modulates gene expression and RNA splicing in hela and K562 cells 79
Pharmacogenomics and analogues of the antitumor agent N6-isopentenyladenosine. 78
A large set of estrogen receptor beta-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cells nuclei. 77
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 77
Mineralcorticoid receptor from rat kidney. Interaction with heparin and purification to a CBG-free stage. 76
Estrogen do not modify MAP kinase-dependent nuclear signalling during stimulation of early G1 progression in human breast cancer cells 76
Characterisation of mainstream cigarette smoke - induced phenotype in human primary bronchial epithelial cells 76
DNMT3B mutations in ICF syndrome are associated to epigenetic alterations of microRNAs having targets involved in immune function. 75
RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. 75
Kleefstra-variant syndrome with heterozygous mutations in EHMT1 and KCNQ2 genes: a case report 74
The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting 74
Quantitative mapping of RNA-mediated nuclear Estrogen Receptor β interactome in human breast cancer cells 74
Enhancement of inducible-type NO synthase gene transcription by protein synthesis inhibitors. Activation of an intracellular signal transduction pathway by low concentrations of cycloheximide. 73
MicroRNA Expression Profiling of Hormone-Responsive Human Breast Cancer Cells Lines. 72
Activation of 'immediate-early' genes by estrogen is not sufficient to achieve stimulation of DNA synthesis in rat uterus. 72
Competitive binding assay for glucocorticoids. Influence of experimental conditions on measurement of the affinity of competitive steroids for the receptor. 71
Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma cells 71
Time-course analysis of genome-wide gene expression data from hormone-responsive human breast cancer cells. 71
Identification of proteins associated with ligand-activated estrogen receptor alpha in human breast cancer cell nuclei by tandem affinity purification and nanoLC-MS/MS. 71
Insulin upregulates VEGF and stabilizes its messenger in endometrial carcinoma cells 70
Analyse génomique de l'action des oestrogènes dans les cancers du sein hormono-sensibles 69
Identification of a hormone-regulated dynamic actin network associated with estrogen receptor alpha in human breast cancer cell nuclei. 69
Accelerated entry into S phase and increased hepatocyte proliferation in c-jun conditional knock-out mice following administration of the CAR agonist TCPOBOP. 68
Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes. 67
17-beta estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G1-arrested human breast cancer cells 67
Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: Identification of novel nuclear cofactors of antiestrogen-ERα complexes by interaction proteomics. 67
Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. 66
Mechanisms of glucocorticoid hormone action. 66
Signaling networks associated with AKT activation in Non-Small Cell Lung Cancer (NSCLC): new insights on the role of the catalytic subunit of phosphatydilinositol-3 kinase PIK3CA 66
Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy 66
Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of hormone regulated genes. 65
Assay of total estradiol receptor in tissue homogenate and tissue fractions by exchange with sodium thiocyanate at low temperature. 65
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukaemia cells. 64
PDGFR-alpha inhibits melanoma growth via CXCL10/IP-10: a multi-omics approach 64
17-beta estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing Erk-1 and -2 MAP kinases activation 63
Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription. 63
Specific binding of estrogen receptor to sites upstream and within the transcribed region of the chicken ovalbumin gene. 61
Bioinformatic and functional analysis of ERE-containing genes 61
Analysis of the estrogen-responsive transcriptome from breast cancer cells: a comparative analysis with three different microarray platforms. 60
DNA methylation dynamic of bone marrow hematopoietic stem cells after allogeneic transplantation 58
Atrial myxomas arise from multipotent cardiac stem cells 57
Inhibition of inducible nitric oxide synthase gene expression by glucocorticoid-induced protein(s) in lipopolysaccharide-stimulated J774 cells. 56
Differences in miRNA expression profiles between ERβ- and ERβ+ breast tumors in vivo and human breast cancer cell lines in vitro reveal a role of these small non-coding RNAs in the hormone-responsive cancer phenotype. 56
Lack of pathogenic mutations in six patients with MMPSI. 56
BSC: a clustering program for DNA array expression data 55
Role of parathyroid hormone in the glucose intolerance of chronic renal failure. 55
Quantitative expression profiling of highly degraded RNA from formalin-fixed, paraffin-embedded breast tumor biopsies by oligonucleotide microarrays. 55
17beta-Estradiol inhibits forskolin-induced vascular endothelial growth factor promoter in MCF-7 breast adenocarcinoma cells 55
Identification of a specific pattern of "immediate-early" gene activation induced by estrogen during mitogenic stimulation of rat uterine cells. 54
In vivo functional analysis of the mouse estrogen receptor gene promoter: a transgenic mouse model to study tissue-specific and developmental regulation of estrogen receptor gene transcription 54
Effects of nitric oxide donors on vascular endothelial growth factor gene induction. 54
Totale 8228
Categoria #
all - tutte 19113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19113

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018327 0000 00 00 5814113115
2018/2019837 631144262 52188 4032 59541238
2019/20201539 4174915827 13949 14911 14416121025
2020/20211296 2013414611 15247 15814 20825171210
2021/20221294 220420 7435 2756 188163165540
2022/20232260 20620894335 290469 19231 408000
Totale 11777